In a fresh injection into global health, European countries and some NGOs committed themselves to contributing almost €630 million, equivalent to $700 million to the World Health Organization (WHO). In…
Air pollution has been associated with approximately 1,400 premature deaths annually across the country, according to an estimated projection made by a respiratory physician-and this exceeds seven times the number…
Leqembi, a new Alzheimer's drug from Biogen and Eisai, promises to extend the quality of life for patients in the early stages of the disease, though it is not a…
The U.S. Food and Drug Administration (FDA) has authorized Novavax's updated Covid-19 vaccine for emergency use in individuals aged 12 and older, marking a significant development as the fall and…
Dexcom Inc. has announced the official launch of Stelo, its new over-the-counter continuous glucose monitor (CGM), now available for purchase in the U.S. This device, designed for individuals with prediabetes…
Mark Bertolini, who took over as CEO of Oscar Health a year ago, has steered the company toward profitability and is now focusing on expanding into the employer market as…
Biogen reported strong second-quarter earnings and revenue on Thursday, surpassing market expectations and prompting the company to raise its full-year guidance. The biotech firm's cost-cutting measures have begun to show…
On Friday, Bristol Myers Squibb announced second-quarter earnings and revenue that exceeded expectations, subsequently raising its full-year guidance as the company implements significant cost-reduction strategies. The pharmaceutical leader adjusted its…
Bhava is a Bevacizumab biosimilar and it will be marketed in strengths of 100 mg/4ml and 400 mg/16ml. Zydus Life said in a statement that Bhava is used for the…
Paradromics, a brain implant company made some announcements regarding the first in-human trial which is to be conducted next year and the company also reiterated that it is taking the…
